We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biochemical Monitoring Devices Measure Analytes in Perspiration

By LabMedica International staff writers
Posted on 25 Mar 2019
A recent paper examined the physiology of sweat secretion in order to advance development of peripheral biochemical monitoring devices that test for analytes in perspiration rather than in blood.

Further development of continuous sensing technologies through new electrochemical sensing techniques will be a major focus of future research. More...
While there has been much investment in wearable technologies to sense analytes, less effort has been directed to understanding the physiology of biofluid secretion. Elucidating the underlying biology is crucial for accelerating technological progress, as the biofluid itself often presents the greatest challenge in terms of sample volumes, secretion rates, filtration, active analyte channels, variable pH and salinity, analyte breakdown, and other confounding factors.

Investigators at the University of Cincinnati (OH, USA) had described in the December 21, 2018, online edition of the journal Lab on a Chip a wearable sweat biosensing device that stimulated sweat and continuously measured sweat ethanol concentrations at 25-second intervals. While this work showed that sweat biosensing could provide continuous and blood-correlated data in an integrated wearable device, unresolved questions included operation for 24 hours or greater and with analytes beyond those commonly explored for in sweat (electrolytes and metabolites).

In a more recent study, the investigators described new sensors attached to a wearable patch the size of a Band-Aid that stimulated sweat even when the patient was cool and resting. The sensor measured specific analytes over time so that the data could be used to determine how the patient was responding to a drug treatment.

"For medications, we can use sweat to get an exact measurement of concentrations in the blood," said senior author Dr. Jason Heikenfeld, professor of electrical engineering, materials science and engineering, and biomedical engineering at the University of Cincinnati. "That is important because once we can measure concentrations of therapeutics in blood, we can look at drug dosing. And that could make current dosing look like something from the Stone Age."

The new study was published in the February 25, 2019, online edition of the journal Nature Biotechnology.

Related Links:
University of Cincinnati


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.